Incidence rate and prevalence of idiopathic pulmonary fibrosis in the United States 2017-2022
This study provides an up-to-date summary of the incidence rate and prevalence of IPF in the United States and shows a substantial burden of comorbidities among patients diagnosed with IPF.
Authors
- Amy L. Olson (ORCID: https://orcid.org/0000-0002-5368-0412)
- Steven D. Nathan (ORCID: https://orcid.org/0000-0002-6270-1617)
- Pratik Pimple (ORCID: https://orcid.org/0000-0002-0746-6810)
- Haikun Bao
- Yanni Fan
Institutions
- Inova Fairfax Hospital (US)
- Boehringer Ingelheim (Brazil) (BR)
- Boehringer Ingelheim (France) (FR)
- Boehringer Ingelheim (United States) (US)
Publication Details
- Journal
- Annals of the American Thoracic Society
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1513/annalsats.202503-262oc
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52